Keyphrases
Osteosarcoma
100%
Tumor Growth
100%
CSF1R
100%
ERK Pathway
100%
PLX3397
100%
Metastatic Burden
100%
CSF-1
40%
Paracrine Signaling
20%
Patient-derived Xenograft
20%
Osteosarcoma Cell Lines
20%
Mouse Model
10%
Solid Tumors
10%
Loss Function
10%
Genetic Modification
10%
Molecular Targets
10%
Osteoblast
10%
Metastasis
10%
Cell Transformation
10%
Signaling Mechanism
10%
Targets for Therapy
10%
Tumorigenesis
10%
Human Osteosarcoma
10%
Pharmacological Inhibitors
10%
Gain-of-function
10%
FDA-approved Drugs
10%
Downstream Signaling
10%
Cell Cycle Arrest
10%
Osteosarcoma Cells
10%
Oncogenic Properties
10%
Functional Alterations
10%
Sleeping Beauty Transposon mutagenesis
10%
Mitotic Cell Cycle
10%
Genetic Perturbation
10%
Human Osteosarcoma Cell Line
10%
Effector Pathways
10%
Cell Line-derived Xenograft
10%
Orthotopic Osteosarcoma
10%
CSF1R Inhibitor
10%
Pexidartinib
10%
Medicine and Dentistry
Tumor Progression
100%
Osteosarcoma
100%
Pexidartinib
100%
Osteosarcoma Cell Line
75%
In Vitro
50%
Xenograft
50%
Paracrine Signalling
50%
Receptor Gene
25%
Solid Malignant Neoplasm
25%
Metastatic Carcinoma
25%
Carcinogenesis
25%
Transposon
25%
Cell Transformation
25%
Cell Cycle Arrest
25%
Colony Stimulating Factor 1
25%
Gene Mutation
25%
Osteoblast
25%
Cell Cycle Checkpoint
25%
Signaling Mechanism
25%
Osteosarcoma Cell
25%
Cell Line
25%
Mutagenesis
25%
Immunology and Microbiology
Osteosarcoma Cell Line
100%
Xenograft
66%
Paracrine Signalling
66%
Cell Line
33%
Signaling Mechanism
33%
Mouse Model
33%
Transposon
33%
Gene Mutation
33%
Cell Transformation
33%
Cell Cycle Arrest
33%
Osteoblast
33%
Receptor Gene
33%
Osteosarcoma Cell
33%
Colony Stimulating Factor 1 Receptor
33%
Mutagenesis
33%
Cell Cycle Checkpoint
33%
Biochemistry, Genetics and Molecular Biology
Tumor Progression
100%
Paracrine Signalling
66%
Genetics
33%
Transposon Mutagenesis
33%
Mouse Model
33%
Signaling Mechanism
33%
Osteoblast
33%
Receptor Gene
33%
Cell Transformation
33%
Gene Mutation
33%
Cell Cycle Arrest
33%
Cell Cycle Checkpoint
33%
Colony Stimulating Factor 1 Receptor
33%
Carcinogenesis
33%
Pharmacology, Toxicology and Pharmaceutical Science
Osteosarcoma
100%
Tumor Growth
100%
Pexidartinib
100%
Mutagenesis
12%
Mouse Model
12%
Molecular Target
12%
Solid Malignant Neoplasm
12%
Receptor
12%
Colony Stimulating Factor 1
12%
Carcinogenesis
12%